Canadian Multicenter Susceptibility Study, with a focus on cephalosporins, from 15 Canadian medical centers. The Canadian Multicenter Study Group
- 1 December 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (12) , 2773-2775
- https://doi.org/10.1128/aac.41.12.2773
Abstract
We have previously reported on the in vitro susceptibilities of 4,482 microorganisms to 10 antimicrobial agents tested as part of a Canadian multicenter study. We now report on the remaining 10 agents tested in that study. Of the cephalosporins reported here, ceftriaxone had the greatest activity (82 to 100% susceptible isolates) against Enterobacteriaceae, compared to ceftizoxime (78 to 100%) and cefoperazone (78 to 100%). Cefoperazone activity against Pseudomonas aeruginosa was 87%, compared to 92% for ticarcillin-clavulanate. All agents had 97% or greater activity against Staphylococcus aureus.Keywords
This publication has 4 references indexed in Scilit:
- Comparative susceptibilities of Klebsieila species, Enterobacter species, and Pseudomonas aeruginosa to 11 antimicrobial agents in a tertiary-care university hospitalThe American Journal of Medicine, 1996
- Comparative activity of eight antimicrobial agents against clinical bacterial isolates from the united states, measured by two methodsThe American Journal of Medicine, 1996
- Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter sppJournal of Antimicrobial Chemotherapy, 1993
- Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group.1992